Study Summary
This trial studies the side effects and best dose of radiation therapy in treating patients with liver cancer that has spread or caused liver damage.
- Liver Cancer
- Bile Duct Cancer
- Liver Cirrhosis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Up to 2 years
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Treatment (radiation therapy)
1 of 1
Experimental Treatment
88 Total Participants · 1 Treatment Group
Primary Treatment: Radiation Therapy · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 14 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many subjects are included in the current research?
"Affirmative. The information available on clinicaltrials.gov reveals that recruitment is ongoing for this research endeavour, which was first posted in February 15th 2016 and last edited June 16th 2021. 88 participants will be accepted from 1 site to take part in the trial." - Anonymous Online Contributor
Has Radiotherapy been validated by the FDA?
"Due to limited data on its efficacy and safety, Radiation Therapy earned a score of 1." - Anonymous Online Contributor
Are there any patients being enrolled in this research endeavor at present?
"Affirmative, the data shared on clinicaltrials.gov verifies that this medical trial is actively enrolling members. The study was initially posted February 15th 2016 and last modified June 16 2021. A total of 88 patients are needed from one centre." - Anonymous Online Contributor